R. Clinton Webb
Dr. Webb’s research focuses on vascular signaling mechanisms in hypertension and sexual dysfunction.
Dr. Webb’s research focuses on vascular signaling mechanisms in hypertension and sexual dysfunction.
Dr. McCarthy's Vascular and Integrative Physiology (VIP) Lab studies vascular physiology and cardiovascular disease pathophysiology. Specific research interests at present include autophagy, energy sensing, and ketogenic interventions.
Dr. Uline's focus is molecular modeling of lipid-protein interactions.
Dr. Wenceslau's lab is to understand vascular physiology in cardiovascular diseases. Study the mechanisms associated with the vascular-immune network in hypertension, metabolic syndrome and sepsis.
Dr. Pinto's research focuses on the promotion of healthy lifestyles, particularly, regular physical activity for the prevention and management of chronic diseases in middle-aged and older adults.
Dr. DiPette's long-term research and clinical interests involve understanding the pathophysiology and novel treatment modalities of hypertension and cardiovascular disease.
Dr. Lessner works in the area of vascular biomechanics, with a focus on how vascular remodeling alters the mechanical function of arteries in the context of atherosclerosis, aortic aneurysm, and aging.
Dr. Sarzynski’s FLEX lab employs a multiomics approach to identify molecular biomarkers associated with the response of cardiometabolic traits to lifestyle and exercise interventions.
Dr. Azhar focuses on the role of transforming growth factor beta ligands in cardiovascular development and cardiovascular disease.
Dr. Bob Price is the Director of the Instrumentation Resource Facility, which is a core biotechnology facility available for use by all in the CTRC.
Dr. Cindy Corbett’s research focuses on health system and self-management interventions to improve health outcomes for adults with chronic conditions.
Dr. Spinale is an internationally renowned cardiovascular scientist, who has directed a translational research effort in the thematic area of cardiovascular remodeling with a particular focus upon heart failure, the main cause of death and disability in South Carolina, for over the past two decades.
Dr. Priviero's lab focuses on the role of the innate immune system in the development of vascular damage, erectile dysfunction, and bladder complications in models of obesity, type-2 diabetes, or hypertension, and how physical exercise or food supplements could modulate the innate immune system to prevent or treat vascular and erectile dysfunction.
Dr. Potts' lab uses developmental biology principles in regenerative medicine approaches to study cardiac development and disease.
Dr. Tan's lab focuses on the pathogenesis of congenital vascular malformations and COVID-19-related vasculopathy.
Dr. Matesic's lab utilizes genetically engineered mouse models to study the effects of how altered regulation of protein homeostasis in the heart can promote developmental defects, lethal arrhythmias, and impaired cardiac relaxation (which contributes to a form of heart failure commonly seen in the aging population).
Dr. Carver’s research focuses on the mechanisms underlying cardiac fibroblast activation and fibrosis in cardiovascular disease and how insight into these may lead to novel therapeutic approaches.
Dr. Shazly's focus is on cardiovascular mechanics and remodeling, with focus of biomaterial-based therapies.
Dr. Goodwin's research focuses on the mechanisms of cardiovascular development and disease.
Dr. Moss’s research focuses on the involvement of protein aggregation in Alzheimer’s disease.
Dr. Wood's research program focuses on identifying neural mechanisms regulating social stress-induced behavioral and autonomic dysfunction, with an emphasis in understanding how females are more stress susceptible.
Dr. Boltin’s research bridges the gap between Artificial Intelligence and Biomedical Engineering. His lab develops translational decision support systems for healthcare using the latest techniques in data science.
Dr. Fan’s research focuses on the role of innate immune cells, particularly macrophages, in atherosclerosis, breast cancer, and cardiotoxicity of cancer therapies.
Dr. Gower's research focuses on developing biomaterials to control immune cell function with applications in treating inflammatory disease and enhancing tissue regeneration.
Dr. Matthews develops new approaches to the sterilization and decellularization of synthetic biomaterials and xenografts. This work supports advances in tissue engineering and regenerative medicine.
Dr. Vento’s research focuses on the neural pathways that underlie motivation and decision-making, and how these circuits are disrupted in mental disease.
Dr. Arnett’s research focus is genetic epidemiology, with specializations in the genomics and pharmacogenomics of cardiovascular disease.
Dr. Wang’s research interest is multidisciplinary fields of cellular transport phenomena and biofluids with super resolution and multimodality imaging and microfluidics, bioimaging and optical measurement method and far field optical and femtosecond lasers based nanoscopy, organ-on-a-chip based on nano/microfluidic technology, fluid dynamics and mixing
Dr. Patel’s research focuses on regulation of inflammation, innate immunity, cell survival and apoptosis by interferon-induced, double-stranded RNA activated protein kinase PKR.
Dr. Liu’s research group is interested in developing translational biosensing technologies for personalized diagnosis and medicine.
Chronic inflammation and immune system dysfunction play important roles in the development of hypertension, cardiovascular, and renal disease. The Ryan laboratory is interested in understanding the mechanistic links driving these relationships. To accomplish this goal, we focus specifically on the autoimmune disorder systemic lupus erythematosus (SLE).
How do blood vessels respond when blocked or injured? Can this response be leveraged to treat inflammatory vascular diseases? The Evans Laboratory studies the vascular response to thrombosis with a view to improving treatments for inflammatory vascular diseases including acute respiratory distress syndrome.